Loading clinical trials...
Loading clinical trials...
Prasugrel in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients
Conditions
Interventions
Prasugrel Hydrochloride 10 MG Oral Tablet
Placebo
Locations
1
Italy
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy
Start Date
July 1, 2020
Primary Completion Date
October 1, 2020
Completion Date
January 1, 2021
Last Updated
June 26, 2020
NCT07410117
NCT03830320
NCT07102160
NCT06658197
NCT05628948
NCT05967741
Lead Sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions